ClinicalTrials.Veeva

Menu

Novel Endpoints in Cough Challenge Testing (NEAT)

NHS Foundation Trust logo

NHS Foundation Trust

Status

Completed

Conditions

Smokers
Healthy
Asthma
Chronic Obstructive Pulmonary Disease
Chronic Cough

Treatments

Other: 24 hour ambulatory cough recording
Other: Cough quality of life questionnaire
Other: Cough challenge test

Study type

Observational

Funder types

Other

Identifiers

NCT01566968
NEAT Version 2, 18/03/11

Details and patient eligibility

About

The sensitivity of a person's cough reflex can be measured by getting them to breathe in (inhale) irritant chemicals. There are different methods by which subjects are asked to inhale these chemicals, either by taking one deep breath in, or by asking them to just continue to take a number of breaths. The purpose of this clinical research study is to see if the coughing responses are different in healthy people and people with respiratory problems that make them cough when they are given these chemicals in these two methods.

Enrollment

98 patients

Sex

All

Ages

18 to 75 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Adult subjects aged 18 and over.

Meet criteria for subject groups as outlined below:

Healthy volunteers:

  • Must be non smokers.
  • No history of respiratory disease.

Healthy smokers:

  • Current smokers with at least 10 pack year history of smoking.
  • Spirometry within normal limits i.e. FEV1 > 80% predicted and FEV1/FVC ratio of > 75% predicted.

Asthma:

  • Physician diagnosis of asthma
  • Stable asthma.
  • Airway hyperresponsiveness to methacoline; PC20< 16mg/ml.
  • Non smokers or ex-smokers with smoking history of less than 10 pack years.

COPD:

  • Physician diagnosis of COPD
  • Ex smokers with smoking history of at least 20 pack years
  • Spirometry demonstating evidence of airflow obstruction i.e. FEV1/FVC ratio of < 70%

Chronic cough:

  • History of dry cough for at least 8 weeks.
  • Normal chest x ray.
  • Non smokers or ex smokers of less than 10 pack years history of smoking.

Exclusion criteria

  • Symptoms of upper respiratory tract infection within the last 4 weeks.
  • Participation in another clinical trial of an investigational drug within 4 weeks.
  • Use of medication likely to alter cough reflex sensitivity i.e. ACE inhibitors, codeine phosphate, morphine sulphate.
  • Patients with severe respiratory disease i.e. FEV1 < 1.0 litre.
  • Use of steroid tablets in previous 2 months or taken more than 3 courses of steroid tablets in the preceding 12 months in subjects with asthma or COPD.
  • Change in asthma treatment in the preceding 6 weeks in asthma group
  • Significant medical co-morbidities likely to affect ability to participate in the trial or affect cough reflex sensitivity e.g. diabetes, stroke, Parkinson's disease, multiple sclerosis etc.

Trial design

98 participants in 5 patient groups

Healthy Volunteers
Description:
Adults between ages of 18-75 inclusive who have never smoked and have no history of any respiratory disease for which they are on regular treatment.
Treatment:
Other: Cough quality of life questionnaire
Other: 24 hour ambulatory cough recording
Other: Cough challenge test
Asthma
Description:
Adults between the ages on 18-75 inclusive who have a physician diagnosis of asthma and have no smoking history or minimal smoking history (less than 10 pack years or in other words less than 20 cigarettes per day for 10 years).
Treatment:
Other: Cough quality of life questionnaire
Other: 24 hour ambulatory cough recording
Other: Cough challenge test
COPD
Description:
Adults between the ages of 18-75 inclusive who have previously been smokers (at least 20 pack years) and have physician diagnosis and spirometry evidence of COPD.
Treatment:
Other: Cough quality of life questionnaire
Other: 24 hour ambulatory cough recording
Other: Cough challenge test
Healthy smokers
Description:
Adults between the ages of 18-75 inclusive who are currently smokers (at least 10 pack years history)but have no history of any respiratory disease and no evidence of COPD on spirometry.
Treatment:
Other: Cough quality of life questionnaire
Other: 24 hour ambulatory cough recording
Other: Cough challenge test
Chronic cough
Description:
Adults between ages of 18-75 inclusive who have history of dry cough for at least 8 weeks and have a normal chest x ray and no smoking history or minimal smoking history (less than 10 pack years).
Treatment:
Other: Cough quality of life questionnaire
Other: 24 hour ambulatory cough recording
Other: Cough challenge test

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems